BioSpace News Archive

Job Trends

GB Sciences and The Colorado Hemp Project Sell First Hemp Crop for $0.7 Million Dollars

Additionally, this first crop provides important seeds and genetics for future crops

December 12, 2018
·
3 min read
Job Trends

University of Phoenix Survey finds Opioid Abuse is a Top Three Concern for Having the Most Detrimental Effect on the US Population in the Next Five Years

Rising healthcare costs and lack of access to affordable insurance are other top concerns

December 12, 2018
·
6 min read
Deals

Bausch Health Enters Into Definitive “Stalking Horse” Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceuticals Inc.

Strategic Acquisition Will Enhance the Salix Gastroenterology Portfolio

December 12, 2018
·
7 min read
Business

Distributed Bio Inc and Good Therapeutics, Inc. Announce Multi-Target Collaboration

Distributed Bio, the global leader in computational optimization of fully human monoclonal antibody libraries, today announced a multi-target partnership with Good Therapeutics Inc.

December 12, 2018
·
2 min read
BioMidwest

Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2018

Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2018.

December 12, 2018
·
1 min read
Biotech Bay

Akero Therapeutics Announces $70 Million in New Financing to Advance Therapeutic Pipeline for NASH, Serious Metabolic Diseases

The financing will support the advancement of Akero’s lead clinical candidate AKR-001

December 12, 2018
·
2 min read
Business

Casma Therapeutics Strengthens Leadership Team with Appointment of Chief Operating Officer, Vice President of People & Culture

Two senior executives who will help lead Casma through its next phase of growth.

December 12, 2018
·
3 min read
Drug Development

AVEO Oncology Announces Immuno-Oncology Clinical Collaboration with AstraZeneca

Phase 1/2 Study will Evaluate Combination of IMFINZI® and FOTIVDA® in First-Line HCC

December 12, 2018
·
7 min read
Drug Development

AR-501 (Cystic Fibrosis) Enrolls First Subject in Phase 1/2a Clinical Trial for Treatment of Chronic Lung Infections in Cystic Fibrosis Patients

Two-Part Randomized, Double-Blinded Placebo Controlled Clinical Study in Healthy Subjects Followed by Cystic Fibrosis Patients Enrolls First Adult Human Volunteer

December 12, 2018
·
7 min read
Business

Encompass Health to present at 37th Annual J.P. Morgan Healthcare Conference

Encompass Health Corp. (NYSE: EHC) today announced it will participate in the 37th Annual J.P. Morgan Healthcare Conference being held Jan. 7-10, 2019, in San Francisco, California.

December 12, 2018
·
1 min read